- Home
- CLSD
CLSD
Clearside Biomedical Inc.
as 11-15-2024 4:00pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | N/A | IPO Year: | 2016 |
| Target Price: | $5.33 | AVG Volume (30 days): | 425.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.90 - $2.12 | Next Earning Date: | 11-12-2024 |
| Revenue: | $7,703,000 | Revenue Growth: | 248.39% |
| Revenue Growth (this year): | -93.13% | Revenue Growth (next year): | 438.58% |
Latest Clearside Biomedical Inc. News
CLSD Breaking Stock News: Dive into CLSD Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
Simply Wall St.
2 days ago
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
4 days ago
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...
Zacks
5 days ago
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
5 days ago
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
GuruFocus.com
6 days ago
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Report Preview: What to Look For
Simply Wall St.
7 days ago
Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years
Pharmaceutical Technology
9 days ago
Santen, Arctic Vision sign deal for ARVN001 to treat UME
Compare CLSD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLSD Clearside Biomedical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.